Home > Insider Trading > Filing (0001209191-19-007428)

Filing Details

Accession Number:: 0001209191-19-007428
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-02-05 17:30:47
Reporting Period:: 2018-10-01

Accepted Time:: 2019-02-05 17:30:47
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
924717	Surmodics Inc	SRDX	Surgical & Medical Instruments & Apparatus (3841)	411356149

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1508798	R Gary Maharaj	9924 West 74Th Street Eden Prairie MN 55344	President & Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2018-10-01	4,100	$72.04	170,767	No	4	S	Direct
Common Stock	Disposition	2018-10-01	200	$72.75	170,567	No	4	S	Direct
Common Stock	Disposition	2018-10-01	700	$74.10	169,867	No	4	S	Direct
Common Stock	Disposition	2019-02-01	668	$51.87	169,199	No	4	S	Direct
Common Stock	Disposition	2019-02-01	925	$53.05	168,274	No	4	S	Direct
Common Stock	Disposition	2019-02-01	840	$54.05	167,434	No	4	S	Direct
Common Stock	Disposition	2019-02-01	300	$55.53	167,134	No	4	S	Direct
Common Stock	Disposition	2019-02-01	100	$56.36	167,034	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 22, 2018.
Reflects the weighted average price of 4,100 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on October 1, 2018 with sale prices ranging from $71.38 to $72.35 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Reflects the weighted average price of 200 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on October 1, 2018 with sale prices ranging from $72.56 to $72.94 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Reflects the weighted average price of 700 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on October 1, 2018 with sale prices ranging from $74.00 to $74.29 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Reflects the weighted average price of 668 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on February 1, 2019 with sale prices ranging from $51.561 to $52.20 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Reflects the weighted average price of 925 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on February 1, 2019 with sale prices ranging from $52.75 to $53.675 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Reflects the weighted average price of 840 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on February 1, 2019 with sale prices ranging from $53.805 to $54.33 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Reflects the weighted average price of 300 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on February 1, 2019 with sale prices ranging from $54.885 to $55.865 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.